ALINITY m EBV ASSAY

ALINITY m EBV ASSAY image
ALINITY m EBV ASSAY image
ALINITY m EBV ASSAY image

ABBOTT'S HIGH PERFORMING TESTING AT DECISIVE MOMENTS IN TRANSPLANT PATIENT CARE

The Alinity m EBV Assay combined with the Alinity m system delivers accurate and timely viral load results, which helps clinicians guide patient care with confidence.

  • Improved Operational Efficiency
    • Alinity m is a continuous and random-access molecular analyzer with a time to first result of less than 115 minutes that provides the ability to eliminate batching procedures and lead to improved laboratory workflow
    • Random access and STAT prioritization provide timely results that support clinicians in their decision to initiate and manage treatment effectively
  • Improved Confidence
    • Dual-target assay design provides robust and accurate detection of EBV
    • Assay is standardized to the 1st World Health Organization (WHO) International Standard for Epstein-Barr Virus for Nucleic Acid Amplification Techniques (NIBSC code: 09/260)
    • Alinity m provides the ability to test Cytomegalovirus (CMV) and Epstein-Barr Virus (EBV) from a single sample, which is critical for transplant patients who are at risk of developing coinfections

INTENDED USE
 

Alinity m EBV is an in vitro polymerase chain reaction (PCR) assay for use with the automated Alinity m System to quantitate Epstein-Barr Virus (EBV) DNA in human EDTA plasma. Alinity m EBV is intended for use as an aid in the diagnosis and management of EBV in transplant patients and other immunocompromised patients. In patients undergoing monitoring of EBV, serial DNA measurements can be used to indicate the need for potential treatment changes and to assess viral response to treatment. The results from Alinity m EBV must be interpreted within the context of all relevant clinical and laboratory findings. Alinity m EBV is not intended to be used in screening blood, blood products, tissue, or organ donors for EBV.

 


Note: Assay availability varies by country, please check with your local Abbott sales representative

 

ABBOTT ALINITY m EBV ASSAY SPECIFICATIONS1-5
Technology Real-time PCR
Assay Run Time < 115 min time to first result
Throughput  300 samples in ~8 hours; 
Up to 1,080 samples in 24 hours*
Probe Design Single-stranded linear probes
Target Region GP350 and EBNA1
Genotypes 1 and 2
Specimen Type Plasma K2 EDTA; K3 EDTA; plasma preparation tubes (PPTs)

Sensitivity

Limit of Detection

LoD = 20 IU/mL
Probit analysis determined that the concentration of EBV DNA detected with 95% probability was 14.29 IU/mL (95% CI: 11.81, 18.22 IU/mL)

Linearity 10 to 400,000,000 IU/mL
Result Units IU/mL or Log (IU/mL)
Precision ≤ 0.26 Log IU/mL Total SD
Sample Input Volume  500 μL
Controls Negative, low positive and high positive controls (single-use tubes)
Calibrator 2 calibrator levels (single-use tubes)
Internal Control DNA (Pumpkin)

*Number of actual samples per 24-hour period may vary based on laboratory practice and workflow. 1. Alinity m EBV AMP Kit Package Insert: 53-608243/R1.  2. Alinity m EBV CAL Kit Package Insert: 53-608245/R1.   3. Alinity m EBV CTRL Kit Package Insert 53-608244/R2. 4. Abbbott Data on File. 5. Alinity m Operations Manual: 54-605001/R10.

AMPLIFY YOUR IMPACT WITH ALINITY M


Alinity m is a fully integrated and automated molecular diagnostics analyzer that uses ReadiFlex technology to deliver the next level of flexibility and efficiency to your lab. 
 

FLEXIBILITY: True random access to perform any test, any time
TURNAROUND TIME: <115 minutes time to first result
THROUGHPUT: 300 samples in ~8 hours

ORDERING INFO